Literature DB >> 11023999

The Werner syndrome protein contributes to induction of p53 by DNA damage.

G Blander1, N Zalle, J F Leal, R L Bar-Or, C E Yu, M Oren.   

Abstract

Mutations in the p53 tumor-suppressor gene promote increased genomic instability and cancer. Mutations in the WRN gene, encoding a DNA helicase, underlie the segmental progeroid Werner syndrome (WS). WS is also associated with increased genomic instability and elevated cancer risk. The p53 and WRN proteins can engage in direct protein-protein interactions. We report that excess WRN elicits increased cellular p53 levels and potentiates p53-mediated apoptosis. Importantly, cells derived from WS patients exhibit an attenuated and delayed induction of p53 by UV or by the topoisomerase I inhibitor camptothecin. These results suggest that WRN may participate in the activation of p53 in response to certain types of DNA damage. Furthermore, the failure to induce p53 effectively may contribute to enhanced genomic instability and elevated cancer risk in WS patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023999     DOI: 10.1096/fj.00-0171fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  8 in total

1.  Werner protein protects nonproliferating cells from oxidative DNA damage.

Authors:  Anna M Szekely; Franziska Bleichert; Astrid Nümann; Stephen Van Komen; Elisabeth Manasanch; Abdelhakim Ben Nasr; Allon Canaan; Sherman M Weissman
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

2.  DNA damage modulates nucleolar interaction of the Werner protein with the AAA ATPase p97/VCP.

Authors:  Juneth Joaquin Partridge; Joseph Onofrio Lopreiato; Martin Latterich; Fred Eliezer Indig
Journal:  Mol Biol Cell       Date:  2003-08-22       Impact factor: 4.138

3.  Loss of VHL promotes progerin expression, leading to impaired p14/ARF function and suppression of p53 activity.

Authors:  Youn-Sang Jung; Su-Jin Lee; Sun-Hye Lee; Ji-Yun Chung; Youn Jin Jung; Sang Hyun Hwang; Nam-Chul Ha; Bum-Joon Park
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

4.  Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1.

Authors:  G Asher; J Lotem; B Cohen; L Sachs; Y Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

Review 5.  Activation and activities of the p53 tumour suppressor protein.

Authors:  E Bálint E; K H Vousden
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

Review 6.  p53 in the DNA-Damage-Repair Process.

Authors:  Ashley B Williams; Björn Schumacher
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

Review 7.  Discovering new medicines targeting helicases: challenges and recent progress.

Authors:  William R Shadrick; Jean Ndjomou; Rajesh Kolli; Sourav Mukherjee; Alicia M Hanson; David N Frick
Journal:  J Biomol Screen       Date:  2013-03-27

8.  Mice with reduced expression of the telomere-associated protein Ft1 develop p53-sensitive progeroid traits.

Authors:  Mattia La Torre; Chiara Merigliano; Romina Burla; Carla Mottini; Giorgia Zanetti; Simona Del Giudice; Mariateresa Carcuro; Ilaria Virdia; Elisabetta Bucciarelli; Isabella Manni; Gianluca Rampioni Vinciguerra; Giulia Piaggio; Mara Riminucci; Ana Cumano; Armando Bartolazzi; Fiammetta Vernì; Silvia Soddu; Maurizio Gatti; Isabella Saggio
Journal:  Aging Cell       Date:  2018-04-10       Impact factor: 9.304

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.